期刊文献+

乙型肝炎病毒特异性小干扰RNA对转基因小鼠毒副作用的评价 被引量:1

Evaluation of Specific Hepatitis B Virus Small Interfering RNA on Adverse Effect of Transgene Mice
原文传递
导出
摘要 目的探讨基于载体的表达性小干扰RNA(siRNA)对乙型肝炎病毒(HBV)转基因小鼠的毒副作用。方法 siRNA表达载体经微静脉注射转染HBV转基因小鼠,设立特异性siRNA组、PBS对照组、阴性质粒对照组及正常Balb/c小鼠对照组。在注射后5 d、12 d、19 d、26 d、33 d、2个月和3个月的不同时间,经其内眦静脉采血检测小鼠ALT水平变化。ELISA方法检测其血清干扰素-α(IFN-α)、肿瘤坏死因子-α(TNF-α)水平。W estern blot检测其肝脏组织中B细胞淋巴瘤2(Bcl-2)、原癌基因(c-Fos)、Bcl-2相关X蛋白(Bax)的表达变化。采用TUNEL染色检测细胞凋亡,HE染色进行组织病理学观察。结果基于聚合酶Ⅲ(PolⅢ)的siRNA表达载体与基于聚合酶Ⅱ(PolⅡ)的siRNA表达载体相比,长期作用机体可使转基因小鼠血清ALT水平显著升高(P<0.05);ELISA分析发现IFN-α水平前者似乎高于后者,但差异无统计学意义(P>0.05)。在治疗26 d,直到治疗3个月,特异性siRNA治疗组与PBS对照组相比,TNF-α表达在PolⅢ组表达明显降低(P<0.05);而PolⅡ组TNF-α表达与PBS对照组比较差异无统计学意义。W estern blot结果表明肝组织Bcl-2、c-Fos表达显著增加,而Bax表达明显降低(P<0.05),且该组凋亡分析表明细胞凋亡被明显抑制。组织形态学可见肝细胞出现二倍体,核仁增大,核膜清晰可见。结论基于PolⅢ的siRNA表达载体与PolⅡ的siRNA表达载体相比对肝细胞有一定的毒副作用,凋亡被抑制,细胞增殖失控。过强表达的HBV特异性siRNA可影响机体的生物网络调控,导致增殖与凋亡的失衡。 Objective To explore the adverse effects of vector based small interfering RNA(siRNA) on the hepatitis B virus(HBV) transgene mice.Methods The constructed siRNA expressed vectors was transfected HBV transgene mice by hydrodynamics-based injection via vena caudalis.The normal Balb/c mice and transgene mice injected with phosphate buffered solution and negative plasmid were set as controls.The effect was observed in different periods(5 d,12 d,19 d,26 d,33 d,2 months and 3 months after injection).The plasma alanine transarninase(ALT) level was detected.Interferon-α(IFN-α) and tumor necrosis factor-α(TNF-α) were detected by enzyme linked immunosorbent assay.The Western blot was performed to detect the changes in Bcl-2,c-Fos and Bax in the liver tissue.The changes in apoptosis and histopathology of liver cells were demonstrated by TUNEL and HE staining.Results Compared with the Pol Ⅱ expression vectors,the Pol Ⅲ expression vectors could raise the plasma ALT level(P0.05).There were no significant differences in IFN-α between the pSilencer 3.1/siRNA group and pSilencer 4.1/siRNA group(P0.05).But the TNF-α level obviously decreased after treatment with pSilencer 3.1 for 26 d compared with the controls.While there was no difference between the Pol Ⅱ groups and the controls till 3 months.Moreover,the expression of Bcl-2 and c-Fos markedly increased,while the Bax was significantly declined in the pSilencer 3.1/siRNA group(Pa0.05).The changes resulted in the abnormal proliferation and the depressant apoptosis of hepatocytes.The histomorphology also demonstrated that the hepatocytes had appeared diploid,big nucleoli and distinct nuclear membrane.Conclusions Compared with the Pol Ⅱ driven siRNA,the Pol Ⅲ driven siRNA has toxicity effect on the hepatocytes,the apoptosis is inhabited and the proliferation is out of control.It seems that the over expressed siRNA can affect the regulation of biology network of the body.It might results in the imbalance of proliferation and apoptosis.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2010年第22期1708-1711,共4页 Journal of Applied Clinical Pediatrics
基金 国家博士后基金(20100470917) 广东省自然科学基金(8451001002000762)
关键词 乙型肝炎病毒 基因治疗 小干扰RNA 毒副作用 hepatitis B virus gene therapy small interfering RNA adverse effect
  • 相关文献

参考文献12

  • 1Carmona S, Jorgensen MR, Kolli S, et al. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA - nanopanicles [ J ]. Mol Pharm,2009,6 (3) :706 - 717.
  • 2Wilson R, Purcell D, Netter HJ, et al. Does RNA interference provide new hope for control of chronic hepatitis B infection[ J] ? Antivir Ther, 2009,14 (7) :879 - 889.
  • 3Starkey JL, Chiari EF, Isom HC. Hepatitis B virus ( HBV ) - specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular ( CCC ) DNA but has no effect on established CCC DNA in vitro[J]. J Gen Virol,2009,90(Pt 1 ) :115 - 126.
  • 4Liu F, Song Y, Liu D. Hydrodynamics -based transfection in animals by systemic administration of plasmid DNA [ J ]. Gene Ther, 1999,6 ( 7 ) : 1258 - 1266.
  • 5Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA :A mouse model of acute hepatitis B virus infection[ J]. Proc Natl Acad Sci U S A ,2002,99 (21) :13825 - 13830.
  • 6任广立,方颖,张卫云,马恒颢,许蔓春,欧巧群,罗爱武,王鲜艳,彭智勇,白雪帆.小干扰RNA抑制HepG2.2.15细胞中乙型肝炎病毒复制与表达[J].实用儿科临床杂志,2008,23(22):1750-1753. 被引量:5
  • 7Woo G, Tomlirtson G, Nishikawa Y, et al. Tenofovir and entecavir are most effective antiviral agents for chronic hepatitis B: A systematic review and bayesian meta- analyses[ J]. C, astroenterology,2010 [ Epub a- head of print].
  • 8Crowther C, Ely A, Hornby J, et al. Efficient inhibition of hepatitis B virus replication in vivo, using polyethylene glycol -modified adenovirus vectors [ J ]. Hum Gene Ther ,2008 ,19 ( 11 ) : 1325 - 1331.
  • 9Ren GL,Fang Y,Ma HH,et al. The short hairpin RNA driven by polymerase II suppresses both wild - type and lamivudine - resistant hepatitis B virus strains [ J ]. Antivir Ther,2007,12 ( 6 ) : 865 - 876.
  • 10Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21 - nucleotide RNAs mediate RNA interference in cultured mammalian cells[ J]. Nature ,2001,411 (6836) :494 - 498.

二级参考文献15

  • 1宋新文,邓存良,盛云建.慢性乙型肝炎患者血清肝细胞生长因子的检测及临床意义[J].新乡医学院学报,2006,23(5):463-464. 被引量:4
  • 2Ely A, Naidoo T, Mufamadi S, et al. Expressed anti -HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo [J]. Mol Ther,2008,16(6) :1105 - 1112.
  • 3MeCauslin CS, Heath V, Colangelo AM,et al. CAAT/enhancer - binding protein delta and cAMP - response element - binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system[ J]. J Biol Chem,2006,281 (26) :17681 - 17688.
  • 4Sherman M I Yurdaydin C, Sollano J, et al. Entecavir for treatment of lamivudine - refractory, HBeAg - positive chronic hepatitis B [ J ]. Gas- troenterology, 2006,130 ( 7 ) : 2039 - 2049.
  • 5Reynolds A-,Leake D,Boese Q,et al. Rational siRNA design for RNA in- terference[J].Nat Biotechno1,2004,22 ( 3 ) :326 - 330.
  • 6Ren GL,Fang Y,Ma HH,et al. The short hairpin RNA driven by polymerase Ⅱ suppresses both wild - type and lamivudine - resistant hepatitis B virus strains [J]. Antivir Ther ,2007 ,12 (6) :865 - 876.
  • 7Carmona S, Ely A, Crowther C, et al. Effective inhibition of HBV replica- tion in vivo by anti - HBx short hairpin RNAs [ J ]. Mol Ther, 2006,13 (2) :411 -421.
  • 8Tan C,Xuan B, Hong J,et al. RNA interference against hepatitis B virus with endoribonuclease - prepared siRNA despite of the target sequence variations[ J ]. Virus Res ,2007,126 ( 1 - 2 ) : 172 - 178.
  • 9Meng Z,Xu Y,Wu J,et al. Inhibition of hepatitis B virus gene expression and replication by endoribonuclease - prepared siRNA [ J ]. J Virol Methods ,2008,150 ( 1 - 2 ) :27 - 33.
  • 10Moore MD,McGarvey MJ,Russell RA ,et al. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors [ J ]. J Gene Med,2005,7 ( 7 ) :918 - 925.

共引文献4

同被引文献14

  • 1Schildgen V, Ziegler S, Tillmann RL, et al. Novel mutation in YMDD motif and direct neighbourhood in a child with chronic HBV - infection and clinical lamivudine and adefovir resistance -a scholarly case [ J ]. Virol J,2010,7 : 167.
  • 2Mcjunkin K, Mazurek A, Premsrirut PK, et al. Reversible suppression of an essential gene in adult mice using transgenic RNA interference[ J]. Proc Natl Acad Sci U S A ,2011,108(17) :7113 -7118.
  • 3Zhou H, Xia XG, Xu Z. An RNA polymerase II construct synthesizes short- hairpin RNA with a quantitative indicator and mediates highly efficient RNAi [ J ]. Nucleic Acids Res,2005,33 ( 6 ) : e62.
  • 4Han Q, Zhang C, Zhang J, et al. Reversal of hepatitis B virus - induced immune tolerance by an immunostimulatory 3p - HBx - sirnas in a reti- noic acid inducible gene I -dependent manner[ J]. Hepatology,2011 [ Epub ahead of print].
  • 5Ebert G, Poeck H, Lucifora J, et al. 5'triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver ceils and mice [ J ]. Gastroenterology,2011,141 (2) :696 -706.
  • 6Kao JH, Chen DS. Global control of hepatitis B virus infection[ J]. Lan- cet Infect Dis ,2002,2 (7) :395 - 403.
  • 7Cassino L, Benetti S, Fay F,et al. Unsuccessful therapy with adefovir and entecavir- tenofovir in a patient with chronic hepatitis B infection with previous resistance to lamivudine : A fourteen - year evolution of hepatitis B virus mutations m J 7. BMC Infect Dis .2011.11 ( 1 ) : 178.
  • 8Liu Y, Wang C, Zhong Y, et al. Evolution CY, suppression of HBV strains with muhidrug resistance to lamivudine. Adefovir dipivoxil and entecavir in a patient with chronic hepatitis B [ J ]. Antivir Ther ,2010 ,15 (8) :1185 - 1190.
  • 9Amini - Bavil - Olyaee S, Herbers U, Luedde T,et al. Impact of hepatitis B e antigen - suppressing mutations on the replication efficiency of ente- cavir- resistant hepatitis B virus strains[ J]. J Viral Hepat,2010 [ Epub ahead of print].
  • 10Chitwood DH,Timmermans MC. Small RNAs are on the move [ J ]. Na- ture,2010,467(7314) :415 -419.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部